ArticleBioactive materials2026
Esophagus extracellular matrix with microenvironmental complexity for esophageal organoids.
Article in Bioactive materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A self-crosslinkable, adhesive intestine-derived extracellular matrix hydrogel enhances organoid retention and restores intestinal barrier integrity.Bioactive materials · 2027Article
- Neural regulation of cancer: from microenvironmental hijacking to systemic circuit co-option.Cellular oncology (Dordrecht, Netherlands) · 2026Review
- Organoids: generation strategies, applications, and future challenges.Stem cell research & therapy · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Esophageal organoids have the potential to serve as promising therapeutics for esophageal mucosal damage, but their application remains largely unexplored. A critical initial step in this application involves addressing the challenges posed by Matrigel (MAT)-based conventional organoid culture, as its tumor-derived origin hinders clinical applications. In this study, we demonstrate the application of decellularized esophagus-derived extracellular matrix (EEM) to the culture and transplantation of esophageal organoids, inspired by excellent biocompatibility and esophageal mimicry of EEM. Our comprehensive proteomic analysis reveals that EEM recapitulates microenvironmental complexity suitable for esophageal organoids by providing diverse esophagus-specific proteins absent in MAT. Esophageal organoids grown in EEM hydrogel can expand through multiple passages and exhibit comparable or elevated expression of esophagus-related genes compared to those grown in MAT. The transplantation of esophageal organoids with EEM not only promotes epithelial regeneration but also mitigates fibrosis at the wound site in a mouse model of an esophageal ulcer. Furthermore, the protein profiles of esophageal tissues undergoing regeneration support the activation of wound healing following organoid transplantation. Taken together, the EEM-based approach for esophageal organoid culture and transplantation would pave the way for advancing esophageal organoid applications by providing a stable and refined matrix to replace MAT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.